Data Availability
All data available, if reviewer ask we could provide.
References
Xing Y, Bronstein Y, Ross MI, et al. Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis. J Natl Cancer Inst. 2011;103:129–42. https://doi.org/10.1093/jnci/djq455.
Buisman FE, van Gelder L, Menke-Pluijmers MB, et al. Non-primary breast malignancies: a single institution’s experience of a diagnostic challenge with important therapeutic consequences—a retrospective study. World J Surg Oncol. 2016;14:1–4.
Papaccio F, Kovacs D, Bellei B, Caputo S, Migliano E, Cota C, Picardo M. Profiling cancer-associated fibroblasts in melanoma. Int J Mol Sci. 2021;22(14):7255.
Carlson JA. Tumor doubling time of cutaneous melanoma and its metastasis. Am J Dermatopathol. 2003;25(4):291–9. https://doi.org/10.1097/00000372-200308000-00003.
Acharya PS, Zukas A, Chandan V, et al. Fibroblast activation protein: a serine protease expressed at the remodeling interface in idiopathic pulmonary fibrosis. Hum Pathol. 2006;37:352–60. https://doi.org/10.1016/j.humpath.2005.11.020.
Bauer S, Jendro MC, Wadle A, et al. Fibroblast activation protein is expressed by rheumatoid myofibroblast-like synoviocytes. Arthritis Res Ther. 2006;8:R171. https://doi.org/10.1186/ar2080.
Rovedatti L, Di Sabatino A, Knowles CH, et al. Fibroblast activation protein expression in Crohn’s disease strictures. Inflamm Bowel Dis. 2011;17:1251–3. https://doi.org/10.1002/ibd.21446.
Mokoala K, Emil N, Lawal I, Antke C, Giesel FL, Sathekge M. [68 Ga] Ga-FAPI versus [18F] F-FDG in malignant melanoma: complementary or counterpoint? Eur J Nucl Med Mol Imaging. 2022;49(7):2445–6.
Novruzov F, Mehdi E, Orucova N, et al. Comparison [68Ga] GaFAPI-46 PET/CT and [18F] FDG PET/CT in breast carcinoma staging: preliminary results of randomised prospective clinical trial from Azerbaijan. Eur J Nucl Med Mol Imaging. 2021;48:S49.
Funding
This study has been supported by the (1) Azerbaijan Science Foundation: AEF/BQM/Az_Türk-2/2021-3(40)-01/01/3 and
(2) SOFIE Co, Totowa, New Jersey, USA.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All procedures performed involving the human participant were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from the patient.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Novruzov, F., Mehdi, E., Orucova, N. et al. Controversies of [68Ga]Ga-FAPI-46 and 2-[18F]FDG findings in metastatic melanoma. Eur J Nucl Med Mol Imaging 51, 609–610 (2024). https://doi.org/10.1007/s00259-023-06444-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00259-023-06444-5